v3.25.2
SCHEDULE OF SEGMENT FINANCIAL INFORMATION BY BUSINESS SEGMENT (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Mar. 31, 2025
Segment Reporting Information [Line Items]      
Cash, cash equivalents and marketable securities $ 6,626   $ 7,148
TOTAL ASSETS 28,114   30,062
Total liabilities (17,706)   (15,721)
Non-controlling interest 481   $ 758
Revenue 1,760 $ 683  
Cost of revenues (1,604) (1,016)  
Cost of revenues 1,604 1,016  
Research and development (3,086) (6,009)  
Selling, general, and administrative (4,687) (7,239)  
Loss from operations (7,617) (13,580)  
Interest and finance expense (548) (964)  
Other non-operating income/(expense) 94 (2)  
Net loss before income taxes (7,691) (12,201)  
Depreciation and amortization 800 700  
Stock-based compensation expense 1,577 3,379  
Cash used in operations (4,526) (10,180)  
Cash used in investing 576 3,114  
Cash from financing 4,066 (264)  
Impact of exchange rates 127 103  
Net change for the period 243 (7,218)  
Business Segment [Member] | Variable Interest Entities [Member] | Parent Company [Member]      
Segment Reporting Information [Line Items]      
Cash, cash equivalents and marketable securities 6,463 21,374  
All other assets 21,651 25,126  
TOTAL ASSETS 28,114 46,500  
Total liabilities (17,706) (28,801)  
Net assets 10,408 17,699  
Non-controlling interest 481 1,570  
Capital expenditures 198 2,673  
Revenue 1,760 683  
Cost of revenues (1,604) (1,016)  
Cost of revenues 1,604 1,016  
Research and development (3,086) (6,009)  
Selling, general, and administrative (4,687) (7,239)  
Loss from operations (7,617) (13,580)  
Interest and finance expense (548) (964)  
Other non-operating income/(expense) 87 1,489  
Net loss before income taxes (8,078) (13,055)  
Depreciation and amortization 805 736  
Stock-based compensation expense 1,577 3,379  
Cash used in operations (4,526) (10,180)  
Cash used in investing 576 3,114  
Cash from financing 4,066 (264)  
Impact of exchange rates 127 111  
Net change for the period 243 (7,218)  
Beyond Air [Member] | Business Segment [Member] | Variable Interest Entities [Member]      
Segment Reporting Information [Line Items]      
Cash, cash equivalents and marketable securities 3,056 13,158  
All other assets 21,241 24,357  
TOTAL ASSETS 24,297 37,515  
Total liabilities (16,779) (27,722)  
Net assets 7,518 9,793  
Non-controlling interest  
Capital expenditures 198 2,650  
Revenue 1,760 683  
Cost of revenues (1,604) (1,016)  
Cost of revenues 1,604 1,016  
Research and development (2,234) (4,078)  
Selling, general, and administrative (3,328) (4,878)  
Loss from operations (5,406) (9,289)  
Interest and finance expense (548) (964)  
Other non-operating income/(expense) 110 1,467  
Net loss before income taxes (5,844) (8,786)  
Depreciation and amortization 795 719  
Stock-based compensation expense 1,000 1,950  
Cash used in operations (3,755) (7,500)  
Cash used in investing 215 5,405  
Cash from financing 4,066 (264)  
Impact of exchange rates 148 21  
Net change for the period 674 (2,338)  
Beyond Cancer Ltd [Member] | Business Segment [Member] | Variable Interest Entities [Member]      
Segment Reporting Information [Line Items]      
Cash, cash equivalents and marketable securities 1,777 8,216  
All other assets 398 769  
TOTAL ASSETS 2,175 8,985  
Total liabilities (530) (1,078)  
Net assets 1,645 7,907  
Non-controlling interest 330 1,570  
Capital expenditures 23  
Revenue  
Cost of revenues  
Cost of revenues  
Research and development (529) (1,930)  
Selling, general, and administrative (952) (2,361)  
Loss from operations (1,481) (4,291)  
Interest and finance expense  
Other non-operating income/(expense) (25) 22  
Net loss before income taxes (1,506) (4,269)  
Depreciation and amortization 10 17  
Stock-based compensation expense 512 1,429  
Cash used in operations (439) (2,680)  
Cash used in investing 361 (2,290)  
Cash from financing  
Impact of exchange rates 31 90  
Net change for the period (47) (4,880)  
NeuroNos Ltd [Member] | Business Segment [Member] | Variable Interest Entities [Member]      
Segment Reporting Information [Line Items]      
Cash, cash equivalents and marketable securities 1,630  
All other assets 12  
TOTAL ASSETS 1,642  
Total liabilities (397)  
Net assets 1,245  
Non-controlling interest 151  
Capital expenditures  
Revenue  
Cost of revenues  
Cost of revenues  
Research and development (323)  
Selling, general, and administrative (407)  
Loss from operations (730)  
Interest and finance expense  
Other non-operating income/(expense) 2  
Net loss before income taxes (728)  
Depreciation and amortization  
Stock-based compensation expense 65  
Cash used in operations (332)  
Cash used in investing  
Cash from financing  
Impact of exchange rates (52)  
Net change for the period $ (384)